Anterogen.Co.Ltd (065660) — Capital Reinvestment Ratio
Latest as of September 2025:
0.10x
Anterogen.Co.Ltd (065660) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩281.98 Million) in capital expenditures (₩27.45 Million). See Anterogen.Co.Ltd (065660) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.10x
Capex / Operating Cash Flow
Operating Cash Flow
₩281.98 Million
KRW
Capital Expenditures
₩27.45 Million
KRW
Data as of
Sep 2025
Most recent filing
Anterogen.Co.Ltd Capital Reinvestment Ratio (2015–2017)
This chart tracks Anterogen.Co.Ltd's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Anterogen.Co.Ltd (2015–2017)
Year-by-year Capital Reinvestment Ratio for Anterogen.Co.Ltd from 2015 to 2017. For live market cap and broader valuation context, see how much is Anterogen.Co.Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 1.68x | ₩379.21 Million | ₩637.46 Million | ▲ +115.4% |
| 2015 | 0.78x | ₩844.49 Million | ₩659.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow